Lululemon Athletica Inc. (LULU) Stock Forecast
Data as of Jun 16, 2026Consumer Cyclical · Current price $116.75 (+0.52%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | Janine Stichter | BTIG | $250.00 | +114.1% |
| Dec 31, 2025 | Jay Sole | UBS | $206.00 | +76.4% |
| Dec 12, 2025 | Anna Andreeva | Piper Sandler | $190.00 | +62.7% |
| Dec 12, 2025 | Randal Konik | Jefferies | $170.00 | +45.6% |
| Nov 25, 2025 | Janine Stichter | BTIG | $303.00 | +159.5% |
| Sep 23, 2025 | Mark Altschwager | Robert W. Baird | $195.00 | +67.0% |
| Sep 5, 2025 | Mark Altschwager | Robert W. Baird | $225.00 | +92.7% |
| Sep 5, 2025 | Anna Andreeva | Piper Sandler | $165.00 | +41.3% |
| Sep 5, 2025 | Peter McGoldrick | Stifel Nicolaus | $205.00 | +75.6% |
| Jan 10, 2025 | Tom Nikic | Needham | $475.00 | +306.8% |
| Jan 7, 2025 | Lululemon to Outperform | Bernstein | $460.00 | +294.0% |
| Dec 9, 2024 | Krisztina Katai | Deutsche Bank | $396.00 | +239.2% |
| Nov 27, 2024 | Brian Nagel | Oppenheimer | $380.00 | +225.5% |
| Nov 6, 2024 | Mark Altschwager | Robert W. Baird | $380.00 | +225.5% |
| Nov 5, 2024 | Scot Ciccarelli | Truist Financial | $360.00 | +208.3% |
| Oct 30, 2024 | Anna Andreeva | Piper Sandler | $260.00 | +122.7% |
| Oct 14, 2024 | Matthew Boss | KeyBanc | $338.00 | +189.5% |
| Oct 14, 2024 | Ashley Owens | Loop Capital Markets | $350.00 | +199.8% |
| Oct 14, 2024 | Adrienne Yih | Barclays | $261.00 | +123.5% |
| Sep 6, 2024 | Mark Altschwager | Robert W. Baird | $350.00 | +199.8% |
Top Analysts Covering LULU
LULU vs Sector & Market
| Metric | LULU | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.93 | 2.52 | 2.41 |
| Analyst Count | 41 | 13 | 19 |
| Target Upside | +26.0% | +387.3% | +17.1% |
| P/E Ratio | 8.45 | 13.94 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-02-01 | $11.41B | $11.48B | $11.54B | 23 |
| 2027-05-01 | $2.49B | $2.54B | $2.59B | 11 |
| 2027-08-01 | $2.65B | $2.70B | $2.75B | 11 |
| 2027-11-01 | $2.72B | $2.77B | $2.83B | 11 |
| 2028-02-01 | $3.86B | $3.93B | $4.01B | 6 |
| 2028-05-01 | $2.57B | $2.62B | $2.67B | 6 |
| 2028-08-01 | $2.62B | $2.67B | $2.73B | 6 |
| 2028-11-01 | $3.67B | $3.74B | $3.82B | 6 |
| 2029-02-01 | $2.62B | $2.67B | $2.73B | 7 |
| 2030-02-01 | $12.97B | $13.37B | $13.56B | 8 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-02-01 | $12.15 | $12.31 | $12.72 | 20 |
| 2027-05-01 | $1.87 | $1.92 | $1.97 | 5 |
| 2027-08-01 | $2.82 | $2.89 | $2.97 | 5 |
| 2027-11-01 | $2.67 | $2.74 | $2.81 | 5 |
| 2028-02-01 | $5.38 | $5.51 | $5.65 | 6 |
| 2028-05-01 | $2.45 | $2.51 | $2.57 | 7 |
| 2028-08-01 | $2.69 | $2.76 | $2.83 | 8 |
| 2028-11-01 | $5.10 | $5.23 | $5.36 | 9 |
| 2029-02-01 | $11.85 | $12.15 | $12.46 | 8 |
| 2030-02-01 | $14.95 | $15.56 | $15.84 | 1 |
Frequently Asked Questions
What is the analyst consensus for LULU?
The consensus among 41 analysts covering Lululemon Athletica Inc. (LULU) is Hold with an average price target of $201.25.
What is the highest price target for LULU?
The highest price target for LULU is $550.00, set by Dana Telsey at Telsey Advisory on 2024-03-22.
What is the lowest price target for LULU?
The lowest price target for LULU is $165.00, set by Anna Andreeva at Piper Sandler on 2025-09-05.
How many analysts cover LULU?
41 analysts have issued ratings for Lululemon Athletica Inc. in the past 12 months.
Is LULU a buy or sell right now?
Based on 41 analyst ratings, LULU has a consensus rating of Hold (2.93/5) with a +26.0% upside to the consensus target of $201.25.
What are the earnings estimates for LULU?
Analysts estimate LULU will report EPS of $12.31 for the period ending 2027-02-01, with revenue estimated at $11.48B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.